7D11 | pdb_00007d11

Solution structure of a WKRY DNA-binding domain


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC1.8 mM [U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
22D 1H-15N HSQC1.8 mM [U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
32D 1H-13C HSQC1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
42D 1H-13C HSQC1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
52D 1H-13C HSQC aromatic1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
63D HNCA1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
73D HN(CO)CA1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
83D HNCACB1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
93D CBCA(CO)NH1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
103D HBHA(CO)NH1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
113D HNCO1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
123D C(CO)NH1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
133D H(CCO)NH1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
143D HCCH-COSY1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
153D CCH-TOCSY1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 500
163D 1H-15N NOESY1.8 mM [U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
173D 1H-13C NOESY aliphatic1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
183D 1H-13C NOESY aromatic1.8 mM [U-95% 13C; U-95% 15N] WRKY1-N, 5 % v/v [U-99% 2H] D2O, 95 % v/v H2O, 25 mM HEPES, 100 mM sodium chloride, 20 uM ZnCl2, 10 mM DTT, 5 % v/v DSS, 2 % v/v protease inhibitor, 0.2 % v/v sodium azide95% H2O/5% D2O125 mM7.01 atm298Bruker AVANCE 900
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE500
2BrukerAVANCE900
NMR Refinement
MethodDetailsSoftware
simulated annealingX-PLOR NIH
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number100
Conformers Submitted Total Number20
Representative Model1 (closest to the average)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1refinementX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore
2structure calculationDYANAGuntert, Braun and Wuthrich
6structure calculationSANEDuggan, Legge, Dyson & Wright
7structure calculationCANDIDHerrmann, Guntert and Wuthrich
3chemical shift assignmentNMRViewJohnson, One Moon Scientific
4peak pickingNMRViewJohnson, One Moon Scientific
8processingNMRPipeDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax